Treatment of Acute Ischemic STroke With Edaravone Dexborneol II (TASTE-2)

clinical trial

Treatment of Acute Ischemic STroke With Edaravone Dexborneol II (TASTE-2) is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT05249920

P6099clinical trial phasephase III clinical trialQ42824827
P582end time2023-04-30
P4135maximum age80
P2899minimum age18
P1132number of participants1362
P4844research interventionantioxidantQ133948
neuroprotective agentQ50377190
edaravoneQ335099
mechanism of actionQ3271540
free radical scavengersQ25401178
P8005research subject recruitment statusrecruitingQ76649708
P580start time2022-03-18
P8363study typeinterventional studyQ78089383
P1476titleTreatment of Acute Ischemic STroke With Edaravone Dexborneol Ⅱ (TASTE-2)